![[HTML version]](/e/graphics/htmlborder.gif)
![[PDF version]](/e/graphics/pdfborder.gif)
![[CIF]](/e/graphics/cifborder.gif)
![[3d view]](/e/graphics/3dviewborder.gif)
![[Structure Factors]](/e/graphics/structurefactorsborder.gif)
![[Supplementary Material]](/e/graphics/supplementarymaterialsborder.gif)
![[CIF check Report]](/e/graphics/checkcifborder.gif)
![[Buy article online]](/logos/buy.gif)
![[Contents scheme]](wk2062contents.gif)
Acta Cryst. (2007). E63, m1959-m1960 [ doi:10.1107/S1600536807029431 ]
2C,2
3C-(diphenylphosphine-1
P)(
-2-propyl-2-azapropane-1,3-dithiolato-1
2S,S':2
2S,S')diiron(Fe-Fe)Abstract: The title compound, [Fe2(C5H11NS2)(C12H11P)(CO)5], has been prepared and characterized as a model compound of the iron hydrogenase active site through controlled CO ligand displacement of (
-SCH2)2N(CH2CH2CH3)[Fe2(CO)6] with diphenylphosphine. The central Fe2S2 structure is in a butterfly conformation, and each Fe atom displays pseudo-square-pyramidal geometry. The phosphine group occupies an apical position. The propyl group on the bridging N atom is in an equatorial position and takes a zigzag form. In the crystal packing, adjacent pairs of molecules are associated by S
S (3.625 Å) intermolecular nonbonded weak interactions.
Online 22 June 2007
Copyright © International Union of Crystallography
IUCr Webmaster